The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index, and 1 are not checked yet.
Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms
Abstract
Malignant transformation from mortal, normal cells to immortal, cancer cells is generally associated with activation of telomerase and subsequent telomere maintenance. A major mechanism to regulate telomerase activity in human cells is transcriptional control of the telomerase catalytic subunit gene, human telomerase reverse transcriptase (hTERT). Several transcription factors, including oncogene products (e.g. c-Myc) and tumor suppressor gene products (e.g. WT1 and p53), are able to control hTERT transcription when over-expressed, although it remains to be determined whether a cancer-associated alteration of these factors is primarily responsible for the hTERT activation during carcinogenic processes. Microcell-mediated chromosome transfer experiments have provided evidence for endogenous factors that function to repress the telomerase activity in normal cells and are inactivated in cancer cells. At least one of those endogenous telomerase repressors, which is encoded by a putative tumor suppressor gene on chromosome 3p, acts through transcriptional repression of the hTERT gene. The hTERT gene is also a target site for viruses frequently associated with human cancers, such as human papillomavirus (HPV) and hepatitis B virus (HBV). HPV E6 protein contributes to keratinocyte immortalization and carcinogenesis through trans-activation of the hTERT gene transcription. In at least some hepatocellular carcinomas, the hTERT gene is a non-random integration site of HBV genome, which activates in cis the hTERT transcription. Thus, a variety of cellular and viral oncogenic mechanisms converge on transcriptional control of the hTERT gene. Regulation of chromatin structure through the modification of nucleosomal histones may mediate the action of these cellular and viral mechanisms. Further elucidation of the hTERT transcriptional regulation, including identification and characterization of the endogenous repressor proteins, should lead to better understanding of the complex regulation of human telomerase in normal and cancer cells and may open up new strategies for anticancer therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,651
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,335
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Research works printed but not linked: 19
- 2000, J ANTIAGING MED, 3, 373
- Horikawa, 1999, Cancer Research, 59, 826
- Takakura, 1999, Cancer Research, 59, 551
- Gunes, 2000, Cancer Research, 60, 2116
- 1992, N BIOL, 4, 97
- Yang, 2001, Cell Growth & Differentiation, 12, 119
- Ducrest, 2001, Cancer Research, 61, 7594
- 1984, SURV SYNTH PATH RES, 3, 342
- Zhang, 2000, Cancer Research, 60, 6230
- Devereux, 1999, Cancer Research, 59, 6087
- Dessain, 2000, Cancer Research, 60, 537
- Kitagawa, 2000, Clinical Cancer Research, 6, 2868
- McGregor, 2002, Cancer Research, 62, 4757
- Wang, 2000, Cancer Research, 60, 5376
- Alfonso-De Matte, 2002, Cancer Research, 62, 4575
- Dimri, 2002, Cancer Research, 62, 4736
- Kyo, 1999, Cancer Research, 59, 5917
- Guo, 2000, Cancer Research, 60, 5922
- Braunstein, 2001, Cancer Research, 61, 5529
Cited by
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers
Seike, M., Goto, A., Okano, T., Bowman, E. D., Schetter, A. J., Horikawa, I., Mathe, E. A., Jen, J., Yang, P., Sugimura, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905234106 · Cited by 500
Self-citationMurakami, Y., Saigo, K., Takashima, H., Minami, M., Okanoue, T., Bréchot, C., & Paterlini-Bréchot, P. (2005) · Gut · doi:10.1136/gut.2004.054452 · Cited by 344
Sp1: Emerging roles—Beyond constitutive activation of TATA-less housekeeping genes
Wierstra, I. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.074 · Cited by 341
TERT—Regulation and Roles in Cancer Formation
Dratwa, M., Wysoczańska, B., Łacina, P., Kubik, T., & Bogunia‐Kubik, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.589929 · Cited by 339
Genetics of hepatocellular tumors
Laurent‐Puig, P., & Zucman‐Rossi, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209547 · Cited by 337
Sato, M., Vaughan, M. B., Girard, L., Peyton, M., Lee, W., Shames, D. S., Ramirez, R. D., Sunaga, N., Gazdar, A. F., Shay, J. W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2521 · Cited by 268
Castelo‐Branco, P., Choufani, S., Mack, S. C., Gallagher, D., Zhang, C., Lipman, T., Zhukova, N., Walker, E. J., Martin, D. C., Merino, D. M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70110-4 · Cited by 265
Faiola, F., Liu, X., Lo, S.-Y., Pan, S., Zhang, K., Lymar, E. S., Farina, A. N., & Martinez, E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10220-10234.2005 · Cited by 221
Genistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanisms
Li, Y., Liu, L., Andrews, L. G., & Tollefsbol, T. O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24398 · Cited by 197
Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells
Cao, Y., Bryan, T. M., & Reddel, R. R. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00815.x · Cited by 185
Epigenetic mechanisms in hepatocellular carcinoma: How environmental factors influence the epigenome
Herceg, Z., & Paliwal, A. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.04.001 · Cited by 183
Zheng, H., Li, L. L., Hu, D. S., Deng, X., & Cao, Y. (2007) · PubMed · Cited by 144
CTCF binds the proximal exonic region of hTERT and inhibits its transcription
Renaud, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki989 · Cited by 143
A Comprehensive Review on Mesenchymal Stem Cell Growth and Senescence
Książek, K. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0830 · Cited by 138
Strategies for using in vitro screens in drug metabolism
Plant, N. J. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)03019-8 · Cited by 138
Promoter‐specific transcriptional interference and c‐myc gene silencing by siRNAs in human cells
Napoli, S., Pastori, C., Magistri, M., Carbone, G. M., & Catapano, C. V. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.139 · Cited by 137
Cheng, Y., Wu, M., Wang, J. C. K., Yeh, K.-T., Goan, Y.-G., Chiou, H., Chen, C., & Lee, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1461 · Cited by 136
Chen, L., Mh, L., Zhang, D., Hao, N.-B., Fan, Y., Wu, Y.-Y., Wang, S.-M., Xie, R., Dc, F., Zhang, H., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.553 · Cited by 133
Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I–transformed cells
Sinha-Datta, U., Horikawa, I., Michishita, E., Datta, A., Sigler-Nicot, J. C., Brown, M., Kazanji, M., Barrett, J. C., & Nicot, C. (2004) · Blood · doi:10.1182/blood-2003-12-4251 · Cited by 130
Self-citationLiu, C., Fang, X., Ge, Z., Jalink, M., Kyo, S., Björkholm, M., Gruber, A., Sjöberg, J., & Xu, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4126 · Cited by 128
Ryan, A. J., Susil, B. J., Jobling, T. W., & Oehler, M. K. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-1109-5 · Cited by 123
Li, Y., Liu, L., & Tollefsbol, T. O. (2009) · The FASEB Journal · doi:10.1096/fj.09-149328 · Cited by 120
Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation
Herceg, Z., Lambert, M.-P., van Veldhoven, K., Demetriou, C. A., Vineis, P., Smith, M. T., Straíf, K., & Wild, C. P. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt212 · Cited by 117
Hopman, A. H. N., Theelen, W., Hommelberg, P. P. H., Kamps, M. A. F., Herrington, C. S., Morrison, L., Speel, E. M., Smedts, F. M. M., & Ramaekers, F. C. S. (2006) · The Journal of Pathology · doi:10.1002/path.2070 · Cited by 112
Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control
Bellon, M., & Nicot, C. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm269 · Cited by 106
Tan, H., Zhang, S., Zhang, J., Zhu, L., Chen, Y., Yang, H., Chen, Y., An, Y., & Liu, B. (2020) · Theranostics · doi:10.7150/thno.47548 · Cited by 97
Viral epigenomes in human tumorigenesis
Fernández, A. F., & Esteller, M. (2010) · Oncogene · doi:10.1038/onc.2009.517 · Cited by 94
Hepatocellular carcinoma: the point of view of the hepatitis B virus
Pollicino, T., Saitta, C., & Raimondo, G. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr108 · Cited by 92
Senescence and immortality in hepatocellular carcinoma
Öztürk, M., Arslan-Ergül, A., Baǧışlar, S., Şentürk, Ş., & Yuzugullu, H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.048 · Cited by 89
Horikawa, I., Chiang, Y. J., Patterson, T., Feigenbaum, L., Leem, S., Michishita, E., Larionov, V., Hodes, R. J., & Barrett, J. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508964102 · Cited by 87
Self-citationZhou, W., Ma, Y., Zhang, J., Hu, J., Zhang, M., Wang, Y., Li, Y., Wu, L., Pan, Y., Zhang, Y., et al. (2017) · Liver International · doi:10.1111/liv.13427 · Cited by 86
Telomere Maintenance Mechanisms in Cancer: Clinical Implications
Reddel, R. R. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140630101047 · Cited by 82
Upregulation of the KIAA1199 gene is associated with cellular mortality
Michishita, E., GARCES, G., Barrett, J., & Horikawa, I. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.028 · Cited by 81
Self-citationJiang, S., Yang, Z., Li, W., Li, X., Wang, Y., Zhang, J., Xu, C., Chen, P., Hou, J., McCrae, M. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040363 · Cited by 79
Cifuentes-Rojas, C., & Shippen, D. E. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.10.003 · Cited by 64
Telomeres, telomerase, and hematopoietic stem cell biology
Greenwood, M. J., & Lansdorp, P. M. (2003) · Archives of Medical Research · doi:10.1016/j.arcmed.2003.07.003 · Cited by 79
Poloni, A., Maurizi, G., Babini, L., Serrani, F., Berardinelli, E., Mancini, S., Costantini, B., Discepoli, G., & Leoni, P. (2010) · Cell Transplantation · doi:10.3727/096368910x536518 · Cited by 78
Telomere stability and telomerase in mesenchymal stem cells
Serakıncı, N., Graakjær, J., & Kølvraa, S. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.005 · Cited by 76
Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology
Meeker, A. K. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.11.002 · Cited by 74
NFX1 Interacts with mSin3A/Histone Deacetylase To Repress hTERT Transcription in Keratinocytes
Xu, M., Luo, W., Elzi, D. J., Grandori, C., & Galloway, D. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01969-07 · Cited by 68
Factors impacting human telomere homeostasis and age-related disease
Gilley, D. P., Herbert, B., Huda, N., Tanaka, H., & Reed, T. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.010 · Cited by 74
Su, M., Xiao, Y., Ma, J., Cao, D., Zhou, Y., Wang, H., Liao, Q., & Wang, W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0663-8 · Cited by 73
Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells
Kim, M.-O., Moon, D., Choi, Y. H., Shin, D. Y., Kang, H. S., Choi, B. T., Lee, J.-D., Li, W., & Kim, G. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.010 · Cited by 71
Wang, Y., Chen, S., Yan, Z., & Pei, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-018-0264-9 · Cited by 56
Wooten, L. G., Song, P., Senkal, C. E., & Öğretmen, B. (2007) · The FASEB Journal · doi:10.1096/fj.07-8621com · Cited by 69
Luan, F., Liu, H., Gao, L., Liu, J., Sun, Z., Ju, Y., Hou, N., Guo, C. H., Liang, X., Zhang, L., et al. (2009) · Gut · doi:10.1136/gut.2008.174029 · Cited by 66
Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
Bousali, M., Papatheodoridis, G., Paraskevis, D. N., & Karamitros, T. (2021) · Microorganisms · doi:10.3390/microorganisms9081787 · Cited by 63
Park, C., Lee, S., Kim, J. Y., Kim, J., Kim, T. M., Lee, S., Choi, S. H., Park, S., & Kim, I. H. (2014) · Oncotarget · doi:10.18632/oncotarget.1975 · Cited by 63
Ge, Z., Liu, C., Björkholm, M., Gruber, A., & Xu, D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.230-237.2006 · Cited by 61
Ge, Z., Li, W., Wang, N., Liu, C., Zhu, Q., Björkholm, M., Gruber, A., & Xu, D. (2009) · The FASEB Journal · doi:10.1096/fj.09-140087 · Cited by 59
Glass, M. C., & Delany, M. E. (2016) · Poultry Science · doi:10.3382/ps/pev369 · Cited by 58
Recent advances in telomere biology: implications for human cancer
Meeker, A. K., & De Marzo, A. M. (2004) · Current Opinion in Oncology · doi:10.1097/00001622-200401000-00007 · Cited by 56
Telomere and Telomerase as Targets for Cancer Therapy
Tian, X., Chen, B., & Liu, X. (2009) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-009-8633-9 · Cited by 56
Human telomerase expression regulation
Machnik, M., Wojtyla, A., & Rubiś, B. (2011) · Biochemistry and Cell Biology · doi:10.1139/o11-037 · Cited by 56
Wooten, L. G., & Öğretmen, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413444200 · Cited by 55
Telomerase as a useful target in cancer fighting—the breast cancer case
Hołysz, H., Lipińska, N., Paszel-Jaworska, A., & Rubiś, B. (2013) · Tumor Biology · doi:10.1007/s13277-013-0757-4 · Cited by 53
Moon, D., Kim, M.-O., Lee, J.-D., Choi, Y. H., & Kim, G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.028 · Cited by 52
Kaufer, B. B., Arndt, S., Trapp, S., Osterrieder, N., & Jarosinski, K. W. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002333 · Cited by 50
Heeg, S., Hirt, N., Queisser, A., Schmieg, H., Thaler, M., Kunert, H., Quante, M., Goessel, G., von Werder, A., Harder, J., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01796.x · Cited by 49
Serakıncı, N., Hoare, S. F., Kassem, M. S., Atkinson, S. P., & Keith, W. N. (2005) · Regenerative Medicine · doi:10.2217/17460751.1.1.125 · Cited by 49
Liu, H., Shi, W., Luan, F., Xu, S., Yang, F., Sun, W., Liu, J., & Ma, C. (2010) · Virus Genes · doi:10.1007/s11262-009-0441-3 · Cited by 47
ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
Chen, Y., Zhou, C., Ji, W., Mei, Z., Hu, B., Zhang, W., Zhang, D., Wang, J., Liu, X., Ouyang, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms11057 · Cited by 47
Potential Anti-HPV and Related Cancer Agents from Marine Resources: An Overview
Wang, S., Zhang, X., Guan, H., & Wang, W. (2014) · Marine Drugs · doi:10.3390/md12042019 · Cited by 45
Human Specific Regulation of the Telomerase Reverse Transcriptase Gene
Zhang, F., Cheng, D., Wang, S., & Zhu, J. (2016) · Genes · doi:10.3390/genes7070030 · Cited by 45
p53 governs telomere regulation feedback too, via TRF2
Horikawa, I., Fujita, K., & Harris, C. C. (2011) · Aging · doi:10.18632/aging.100271 · Cited by 41
Self-citationNourbakhsh, M., Golestani, A., Zahrai, M., Modarressi, M. H., Malekpour, Z., & Karami‐Tehrani, F. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.07.021 · Cited by 41
Lepreux, S., Rebouissou, S., Bail, B. L., Saric, J., Balabaud, C. P., Bloch, B., Martin‐Négrier, M., Zucman‐Rossi, J., & Bioulac‐Sage, P. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.021 · Cited by 41
Tuntiwechapikul, W., Taka, T., Songsomboon, C., Kaewtunjai, N., Imsumran, A., Makonkawkeyoon, L., Pompimon, W., & Lee, T. R. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2010.1191 · Cited by 41
Yang, Y.-J., Chen, H., Huang, P. C., Li, C.-H., Dong, Z.-H., & Hou, Y. (2011) · Clinical and investigative medicine · doi:10.25011/cim.v34i4.15366 · Cited by 40
Hu, Z., Wu, H., Li, Y., Hou, Q., Wang, Y., Li, S., Xia, B., & Wu, S. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000216 · Cited by 40
Mo, J., Xia, Y., Ning, Z., Wade, T. J., & Mumford, J. L. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11532 · Cited by 40
Benanti, J. A., Wang, M. L., Myers, H. E., Robinson, K. L., Grandori, C., & Galloway, D. A. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0372 · Cited by 39
Hedgehog Signaling Regulates Telomerase Reverse Transcriptase in Human Cancer Cells
Mazumdar, T., Sandhu, R. S., Qadan, M. A., DeVecchio, J., Magloire, V., Agyeman, A., Li, B., & Houghton, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075253 · Cited by 38
EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma
Fumoto, S., Hiyama, K., Tanimoto, K., Noguchi, T., Hihara, J., Hiyama, E., Noguchi, T., & Nishiyama, M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.08.021 · Cited by 37
MicroRNAs in HPV associated cancers: small players with big consequences
Satapathy, S., Batra, J., Jeet, V., Thompson, E. W., & Punyadeera, C. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1339603 · Cited by 37
Cheng, Y., Wu, T., Chen, C., Chou, M., Ko, J., & Lee, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0850 · Cited by 36
The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy
Zhang, M., Chen, H., Liu, H., & Tang, H. (2024) · Biomarker Research · doi:10.1186/s40364-024-00611-y · Cited by 35
Identification of senescence-associated genes in human bone marrow mesenchymal stem cells
Ryu, E., Hong, S. H., Kang, J., Woo, J., Park, J., Lee, J., & Seo, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.111 · Cited by 35
Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells
Zhu, Z., Wilson, A. T., Gopalakrishna, K. N., Brown, K. E., Luxon, B. A., & Schmidt, W. N. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21644 · Cited by 34
TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter
Rajagopalan, D., Pandey, A. K., Xiuzhen, M. C., Lee, K. K., Hora, S., Zhang, Y., Chua, B. H., Kwok, H. S., Bhatia, S. S., Deng, L., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006681 · Cited by 33
Zou, S.-Q., Qu, Z.-L., Li, Z., & Wang, X. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i15.2259 · Cited by 33
Schütze, D. M., Kooter, J. M., Wilting, S. M., Meijer, C. J. L. M., Quint, W. G. V., Snijders, P. J. F., & Steenbergen, R. D. M. (2015) · Epigenetics · doi:10.4161/15592294.2014.990787 · Cited by 32
Zhu, Q., Liu, C., Ge, Z., Fang, X., Zhang, X., Strååt, K., Björkholm, M., & Xu, D. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001446 · Cited by 32
Yuen, J. W. M., Gohel, M. D. I., & Au, D. W. T. (2007) · Nutrition and Cancer · doi:10.1080/01635580701525869 · Cited by 32
Qu, Z.-L. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i36.5627 · Cited by 32
Ou, R., Lv, M., Liu, X., Lv, J., Zhao, J., Zhao, Y., Li, X., Li, W., Zhao, L., Lǐ, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000762r · Cited by 31
Muñoz, J. P., González, C., Parra, B., Corvalán, A. H., Tornesello, M. L., Eizuru, Y., & Aguayo, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038178 · Cited by 31
Oh, B.-K., Kim, Y., Park, Y. N., Choi, J., Kim, K. S., & Park, C. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00532.x · Cited by 31
Okabe, S., Tauchi, T., Nakajima, A., Sashida, G., Gotoh, A., Broxmeyer, H. E., Ohyashiki, J. H., & Ohyashiki, K. (2007) · Stem Cells and Development · doi:10.1089/scd.2007.9994 · Cited by 31
Murakami, J., Asaumi, J., Kawai, N., Tsujigiwa, H., Yanagi, Y., Nagatsuka, H., Inoue, T., Kokeguchi, S., Kawasaki, S., Kuroda, M., et al. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0976-x · Cited by 30
Regulation of Telomerase by Human PapillomavirusesPreprint
Galloway, D. A., Gewin, L. C., Myers, H. E., LUO, W., Grandori, C., Katzenellenbogen, R. A., & McDougall, J. K. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.041 · Cited by 30
Toaldo, C., Pizzimenti, S., Cerbone, A., Pettazzoni, P., Menegatti, E., Berardi, D., Minelli, R., Giglioni, B., Dianzani, M. U., Ferretti, C., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00966.x · Cited by 29
Cellular senescence, telomere recombination and maintenance
Yang, Q. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167806 · Cited by 28
Liu, S., Liu, H., Qin, R., Shu, Y., Liu, Z.-D., Zhang, P., Duan, C., Hong, D., Yu, J. Z., & Zou, L. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.164 · Cited by 28
Possible Oncogenic Viruses Associated with Lung Cancer
Hu, Y. W., Ren, S., He, Y., Wang, L., Chen, C., Tang, J., Liu, W., & Yu, F. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s263976 · Cited by 27
Xu, M., Katzenellenbogen, R. A., Grandori, C., & Galloway, D. A. (2013) · Virology · doi:10.1016/j.virol.2013.07.014 · Cited by 27
Molecular genetics of human cervical cancer: role of papillomavirus and the apoptotic cascade
Ledwaba, T., Dlamini, Z., Naicker, S., & Bhoola, K. D. (2004) · Biological Chemistry · doi:10.1515/bc.2004.083 · Cited by 27
Telomerase regulation in hematological cancers: A matter of stemness?
Deville, L., Hillion, J., & Ségal-Bendirdjian, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.016 · Cited by 27
Molecular mechanisms for the p38-induced cellular senescence in normal human fibroblast
Harada, G., Neng, Q., Fujiki, T., & Katakura, Y. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu040 · Cited by 26
Telomerase Activation in Human Hepatocarcinogenesis
Hytiroglou, P., & Theise, N. D. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00521.x · Cited by 26
Metadata
- Authors
- Horikawa, I., & Barrett, J. C.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Horikawa, I.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-05-22
- Volume
- 24
- Issue
- 7
- Pages
- 1167-1176
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2170172182
- Cited by
- 211
- References
- 125
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2022: 2 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 8 · 2015: 4 · 2014: 13 · 2013: 11 · 2012: 8
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Carcinogenesis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Georgetown University
- Korea Advanced Institute of Science and Technology
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- hTERT, telomerase, transcriptional regulation, telomere maintenance, c-Myc, WT1, p53, E6 oncoprotein, hepatitis B virus, viral oncogenesis, chromatin structure, histone modifications, cell immortalization, hepatocellular carcinoma, cancer therapy
- MeSH terms
- Cell Transformation, Viral, DNA-Binding Proteins, Humans, Transcription, Genetic, Transcriptional Activation, Gene Expression Regulation, Enzymologic, Telomere, Telomerase, DNA Methylation, Papillomaviridae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review